Injection Site Rotation
Also known as: site rotation · rotating sites
Injection site rotation means moving each injection to a different spot so the same patch of tissue is not injected repeatedly.
Rotation is a planned pattern for where each injection goes: across body areas (abdomen, thighs, upper arms) and across spots within one area. The main thing it prevents is lipohypertrophy, a thickened, rubbery or lumpy swelling of the fat under the skin that forms with repeated injections in the same place.
The evidence comes mostly from insulin, the most studied injected peptide. A meta-analysis of 51 studies found that incorrect site rotation was the strongest risk factor for lipohypertrophy, with about nine times the odds (prevalence odds ratio 8.85), followed by needle reuse (3.20). Approved peptide labels also call for rotation: the tesamorelin label tells users to rotate within the abdomen to reduce injection-site reactions, which occurred in 25% of treated patients versus 14% on placebo in the first 26 weeks of trials.
Why it matters
Lipohypertrophy changes absorption. In a crossover study of 13 people with type 1 diabetes, insulin injected into lipohypertrophic tissue was absorbed less (area under the curve 131 versus 165 h·mU/L, peak 61 versus 79 mU/L) and much less predictably (variability of total absorption 52% versus 11%) than injections into normal tissue.
For anyone injecting a peptide repeatedly, that means a favorite spot can quietly make doses weaker and less consistent. Rotating sites, and not injecting into lumps you can feel, keeps absorption more consistent. The same meta-analysis found higher odds of lipohypertrophy with more than two injections a day and with more than five years of injecting, so frequent, long-term use is when rotation matters most.
How to do it
- Divide each injection area into zones, for example four quarters of the abdomen staying at least 2 inches (5 cm) from the navel.
- Use one zone at a time and move to a new spot within it for each injection.
- Switch zones on a fixed schedule so each one gets time to recover.
- Feel and look at your sites regularly; skip any spot with lumps, hardness, bruising or scarring.
- Use a new needle each time, since needle reuse is also linked to lipohypertrophy.
Days before reusing a spot = number of zones × spots per zone (one injection a day)
Use one abdominal zone per week and a different spot in it each day. With 4 zones and 7 spots per zone, you return to any one spot every 4 × 7 = 28 days. Check: 28 ÷ 7 = 4 weeks, one per zone.
Common mistakes
- Using the same comfortable spot every time.
- Injecting into a lump because it hurts less; lipohypertrophic tissue absorbs poorly and unpredictably.
- Rotating between areas but always hitting the same point within each area.
- Reusing needles.
- Not checking sites by touch, since early lumps can be easier to feel than see.
Sources
- Systematic reviewRisk factors for Lipohypertrophy in People With Insulin-Treated Diabetes: A Systematic Meta-Analysis. J Diabetes Sci Technol, 2026. PMID 40109173.
- Clinical trialInsulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control. Diabetes Care, 2016. PMID 27411698.
- Prescribing informationEGRIFTA WR (tesamorelin) for injection - prescribing information and instructions for use. DailyMed, U.S. National Library of Medicine, 2025.
Page updated . How we grade evidence: methodology.
Related Terms
Subcutaneous (SubQ) Injection
A subcutaneous (SubQ) injection delivers a drug into the fat layer between the skin and the muscle, where it is absorbed gradually.
Subcutaneous Absorption Rate
Subcutaneous absorption rate is how fast a drug injected into the fatty layer under your skin moves into your bloodstream.
Intramuscular (IM) Injection
An intramuscular (IM) injection delivers a drug into a muscle, using a longer needle than a subcutaneous injection, at sites such as the deltoid.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial